O
Oncorus
oncorus.com
Website unreachable since Oct 27, 2026
Oncorus Inc is a preclinical-stage biopharmaceutical company developing self-amplifying RNA therapies for cancer treatment, utilizing intravenous and intratumoral administration to target and eliminate tumor cells. Its product candidates, ONCR-021 and ONCR-788, leverage coxsackievirus A21 and Seneca Valley Virus to stimulate immune responses against tumors.
Traction –/10
HQ unknown
- Biotechnology
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Oncorus Inc is a preclinical-stage biopharmaceutical company developing self-amplifying RNA therapies for cancer treatment, utilizing intravenous and intratumoral administration to target and eliminate tumor cells. Its product candidates, ONCR-021 and ONCR-788, leverage coxsackievirus A21 and Seneca Valley Virus to stimulate immune responses against tumors.